Bioventix PLC (LON:BVXP - Get Free Report)'s stock price hit a new 52-week low on Tuesday . The company traded as low as GBX 2,552 ($33.03) and last traded at GBX 2,603.90 ($33.70), with a volume of 13413 shares traded. The stock had previously closed at GBX 2,590 ($33.52).
Bioventix Price Performance
The firm has a market capitalization of £143.53 million, a P/E ratio of 17.73 and a beta of 0.35. The firm's fifty day moving average price is GBX 2,908.58 and its 200-day moving average price is GBX 3,370.95.
Bioventix Company Profile
(
Get Free Report)
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
See Also
Before you consider Bioventix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioventix wasn't on the list.
While Bioventix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
